product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Keratin 20 (D9Z1Z) XP Rabbit mAb
catalog :
13063
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D9Z1Z
reactivity :
human, mouse
application :
western blot, immunocytochemistry, immunohistochemistry - paraffin section
more info or order :
Cell Signaling Technology product webpage
citations: 8
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; 1:2500; loading ...; fig 3e
Chen L, Luo S, Dupre A, Vasoya R, Parthasarathy A, Aita R, et al. The nuclear receptor HNF4 drives a brush border gene program conserved across murine intestine, kidney, and embryonic yolk sac. Nat Commun. 2021;12:2886 pubmed publisher
  • immunohistochemistry - paraffin section; mouse; 1:800; loading ...; fig 5e
Quach C, Song Y, Guo H, Li S, Maazi H, Fung M, et al. A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice. Nat Commun. 2019;10:5681 pubmed publisher
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Zhao H, Yan C, Hu Y, Mu L, Huang K, Li Q, et al. Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells. Int J Oncol. 2019;54:893-904 pubmed publisher
  • immunohistochemistry - paraffin section; human; loading ...; fig 8d
Rasheed K, Abdulsalam I, Fismen S, Grimstad Ø, Sveinbjørnsson B, Moens U. CCL17/TARC and CCR4 expression in Merkel cell carcinoma. Oncotarget. 2018;9:31432-31447 pubmed publisher
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 2b
Dow L, Fisher J, O Rourke K, Muley A, Kastenhuber E, Livshits G, et al. Inducible in vivo genome editing with CRISPR-Cas9. Nat Biotechnol. 2015;33:390-394 pubmed publisher
Fujino S, Miyoshi N, Ito A, Yasui M, Ohue M, Ogino T, et al. Crenolanib regulates ERK and AKT/mTOR signaling pathways in RAS/BRAF-mutated colorectal cancer cells and organoids. Mol Cancer Res. 2021;: pubmed publisher
Han T, Goswami S, Hu Y, Tang F, Zafra M, Murphy C, et al. Lineage Reversion Drives WNT Independence in Intestinal Cancer. Cancer Discov. 2020;10:1590-1609 pubmed publisher
Perekatt A, Shah P, Cheung S, Jariwala N, Wu A, Gandhi V, et al. SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium. Cancer Res. 2018;78:4878-4890 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.